TherapeuticsMD (TXMD) Leases (2019 - 2025)
Historic Leases for TherapeuticsMD (TXMD) over the last 7 years, with Q3 2025 value amounting to $5.5 million.
- TherapeuticsMD's Leases fell 1248.81% to $5.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.5 million, marking a year-over-year decrease of 1248.81%. This contributed to the annual value of $6.1 million for FY2024, which is 1121.78% down from last year.
- Per TherapeuticsMD's latest filing, its Leases stood at $5.5 million for Q3 2025, which was down 1248.81% from $5.7 million recorded in Q2 2025.
- TherapeuticsMD's 5-year Leases high stood at $9.2 million for Q1 2021, and its period low was $5.5 million during Q3 2025.
- Its 5-year average for Leases is $7.2 million, with a median of $7.2 million in 2023.
- Examining YoY changes over the last 5 years, TherapeuticsMD's Leases showed a top increase of 565.91% in 2021 and a maximum decrease of 1588.58% in 2021.
- Over the past 5 years, TherapeuticsMD's Leases (Quarter) stood at $8.2 million in 2021, then dropped by 7.94% to $7.6 million in 2022, then decreased by 9.33% to $6.9 million in 2023, then decreased by 11.22% to $6.1 million in 2024, then fell by 9.62% to $5.5 million in 2025.
- Its last three reported values are $5.5 million in Q3 2025, $5.7 million for Q2 2025, and $5.9 million during Q1 2025.